Louisiana State Employees Retirement System Buys New Shares in GE HealthCare Technologies Inc. $GEHC

Louisiana State Employees Retirement System bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 1st quarter, Holdings Channel.com reports. The firm bought 53,100 shares of the company’s stock, valued at approximately $3,780,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Laurel Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth approximately $27,000. Godfrey Financial Associates Inc. purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC increased its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other news, insider Frank R. Jimenez bought 1,750 shares of GE HealthCare Technologies stock in a transaction dated Thursday, April 30th. The shares were acquired at an average cost of $60.45 per share, with a total value of $105,787.50. Following the completion of the transaction, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was purchased at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 21,847 shares of company stock worth $1,361,355 over the last 90 days. 0.36% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Piper Sandler decreased their price target on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. Argus dropped their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a report on Tuesday, May 19th. Jefferies Financial Group cut their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Finally, Mizuho dropped their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.20.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $65.76 on Friday. The firm has a fifty day moving average of $64.51 and a 200-day moving average of $73.96. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $29.91 billion, a P/E ratio of 15.73, a PEG ratio of 1.79 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the previous year, the firm posted $1.01 EPS. The business’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.